(Q30434868)

21 June 2017

1 reference

title

Trivalent intranasal influenza vaccine, live (English)

1 reference

21 June 2017

1 reference

Michelle W McCarthy

1 reference

21 June 2017

Denise R Kockler

series ordinal

1 reference

21 June 2017

language of work or name

English

0 references

publication date

19 October 2004

1 reference

Annals of Pharmacotherapy

21 June 2017

published in

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

2086-2093

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 June 2017

cites work

1 reference

Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine

21 January 2018

1 reference

Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children

21 January 2018

1 reference

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

21 January 2018

1 reference

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children

21 January 2018

1 reference

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

21 January 2018

1 reference

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

21 January 2018

1 reference

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

21 January 2018

1 reference

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

21 January 2018

1 reference

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

21 January 2018

1 reference

Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers

21 January 2018

1 reference

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

21 January 2018

1 reference

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children

21 January 2018

1 reference

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

21 January 2018

1 reference

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

21 January 2018

1 reference

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E191

1 reference

21 June 2017

1 reference